Novo Nordisk AS

Pharmaceuticals
Denmark
Earnings Per Share Growth (%)34.26%
Cost of Goods Sold (US$ Millions)$2,363
Current Liabilities (US$ Millions)$5,966
Total Assets (US$ Millions)$8,048
Long Term Debt$0
Return on Equity86.51%
Revenue (US$ Millions)$15,753
Total Company Assets$13,399
Revenue Growth (%)21.53%
Net Income (US$ Millions)$5,088
Earnings Per Share (US$)$34.26
Total Equity (US$ Millions)$6,856
Profit Margin (%)32.30%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$1,862